866-997-4948(US-Canada Toll Free)

Contraceptives Market (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives, Male Condoms, Female Condoms, Intrauterine Devices, Sub-Dermal Contraceptive Implants, Contraceptive Vaginal Rings, Contraceptive Diaphragms, Contraceptive Sponges, Non-Surgical Permanent Contraception Devices) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Published By :

Transparency

Published Date : Dec 2014

Category :

Medical Equipments

No. of Pages : 106

Contraceptives are defined as drugs and devices that help in preventing pregnancy. These devices also prevent spreading of sexually transmitted infection. Various awareness initiatives taken by market players is the major factor propelling the growth of contraceptives market. Bayer HealthCare, a major player in the contraceptives market, in coalition with 11 NGOs, organizes the World Contraception Day every year on September 26 to spread awareness about contraceptive methods, enabling young people to take right decision about their reproductive health.

This report provides in-depth analysis of the global contraceptives drugs and devices market. The stakeholders for this report include companies involved in the research and development, manufacturing and commercialization of contraceptive drugs and devices, suppliers and new entrants who are planning to invest in this market. For providing a snapshot of this market to the stakeholders, executive summary section is included in this report, which summarizes the market size, trends and competition for different contraceptive drugs and devices in four major geographies.

The market overview section of this report analyzes market dynamics such as drivers, restraints and opportunities that influence the contraceptives market in the current and future scenario. Further, Porter’s five forces analysis and market attractiveness analysis have been included in market overview section in order to explain the intensity of competition in the market. Porter’s five forces analysis is also elucidated in the section to understand the attractiveness of the contraceptive market in terms of five different attributes that have an effect on the sustenance of the players in the contraceptives market. Competitive scenario among the market players is analyzed through a heat map of major market players in the competitive landscape section of the report. All these factors will help the market players to decide about the business strategies and plans to be incurred in future for strengthening their position in the global market.

Based on the product types, the global contraceptives market is segmented into two major segments, namely, contraceptive drugs and contraceptive devices. Contraceptive drugs are further categorized into three segments including contraceptive pills, contraceptive injectables and topical contraceptives. Contraceptives devices segment is also further classified into two segments, male contraceptive devices and female contraceptive devices. Male contraceptive devices segment includes male condoms while female contraceptive devices are further differentiated into female condoms, intrauterine devices (IUDs), contraceptive sponges, contraceptive vaginal rings, subdermal contraceptive implants, contraceptive diaphragms and non-surgical permanent contraceptive devices. IUDs market is further segmented into copper IUD and hormonal IUD. Market revenue in terms of USD million for the period 2012 to 2020 along with the compound annual growth rate (CAGR %) from 2014 to 2020 is analyzed for the various types of contraceptive drugs and devices, considering 2013 as the base year. 

Geographically, the contraceptives market has been differentiated into four major regions: North America, Europe, Asia Pacific and Rest of the World (RoW). This section of the report provides market estimation in terms of revenue (USD million) of contraceptives market in these four regions from 2012 to 2020. Market revenue for contraceptive drugs and devices is also provided for geographies along with CAGR % for period 2014 to 2020, considering 2013 as the base year.

This report also includes recommendations section that will assist new companies in establishing their presence and market players in expanding their market share in the contraceptives market. The report concludes with the company profile section which includes company overview, financial overview, product portfolio, business strategies and recent developments for market players. The major players that are profiled in the report include Actavis, Inc., Bayers AG, Church & Dwight, Co., Inc., CooperSurgical, Inc., Mayer Laboratories, Inc., Merck & Co., Inc., Reckitt Benckiser plc, Pfizer, Inc., Teva Pharmaceutical Industries Ltd. and The Female Health Company. 
The global contraceptives market is segmented into the following categories:


Global Contraceptives Market, by Product Types 

  • Drugs
  • Oral Contraceptive Pills
  • Contraceptive Injectables
  • Topical Contraceptives
  • Devices
  • Male Contraceptive Devices (Male Condoms)
  • Female Contraceptive Devices
  • Female Condoms
  • Sub-dermal Contraceptive Implants
  • Intrauterine Devices
  • Contraceptive Vaginal Rings
  • Contraceptive Diaphragm
  • Contraceptive Sponges
  • Non-Surgical Permanent Contraception Device

Global Contraceptives Market, by Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World (RoW)

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 List of Abbreviations

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Contraceptives Market
2.2 Comparative Analysis: Global Contraceptives Market, by Geography, 2013 & 2020 (Value %)

Chapter 3 Global Contraceptives Market Overview
3.1 Introduction
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 High incident rate of unintended pregnancies is leading to unmet contraceptive needs, hence driving the contraceptives market
3.2.1.2 Awareness programs by government and NGOs are promoting the use of contraceptives globally
3.2.1.3 Implementation of the Patient Protection Act or the Affordable Care Act increased the use of contraceptives in North America
3.2.2 Market Restraints
3.2.2.1 Side effects associated with the use of contraceptive drugs and devices induce people to opt for natural and permanent contraceptive methods
3.2.2.2 Rising prevalence of infertility among women and aging population are limiting the use of contraceptives
3.2.2.3 Ethical and social issues restrict the use or subsidies on contraceptives in some countries
3.2.3 Market Opportunities
3.2.3.1 Presence of large unmet contraceptive needs in emerging Asian and African Economies would drive the contraceptives market
3.2.3.2 Presence of strong contraceptive pipeline would support the global contraceptives market during the forecast period
3.3 Porter’s Five Forces Analysis: Global Contraceptives Market
3.3.1 Bargaining Power of Suppliers
3.3.2 Bargaining Power of Buyers
3.3.3 Threat of Substitutes
3.3.4 Threat of New Entrants
3.3.5 Competitive Rivalry
3.4 Market Attractiveness Analysis: Global Contraceptives Market, by Geography
3.5 Competitive Landscape: Global Contraceptives Market, by Key Players
3.5.1 Heat Map Analysis for Key Market Players: Global Contraceptive Drugs Market
3.5.2 Heat Map Analysis for Key Market Players: Global Contraceptive Devices Market

Chapter 4 Global Contraceptives Market, by Product Type
4.1 Introduction
4.1.1 Comparative Analysis: Global Contraceptives Market Revenue, by Product Type, 2013 & 2020 (%)
4.2 Contraceptive Drugs
4.2.1 Global Contraceptive Drugs Market Revenue, by Drug Type, 2012 – 2020 (USD Million)
4.2.2 Oral Contraceptive Pills
4.2.2.1 Global Oral Contraceptive Pills Market Revenue, 2012 – 2020 (USD Million)
4.2.3 Contraceptive Injectables
4.2.3.1 Global Contraceptive Injectables Market Revenue, 2012 – 2020 (USD Million)
4.2.4 Topical Contraceptives
4.2.4.1 Global Topical Contraceptives Market Revenue, 2012 – 2020 (USD Million)
4.3 Contraceptive Devices
4.3.1 Comparative Analysis: Global Contraceptive Devices Market, by Device Type, 2013 & 2020 (%)
4.3.2 Male Contraceptive Devices (Male Condoms)
4.3.2.1 Global Male Contraceptive Devices Market Revenue, 2012 – 2020 (USD Million)
4.3.2.2 Competitive Landscape: Global Male Contraceptive Devices (Male Condoms) Segment
4.3.3 Female Contraceptive Devices
4.3.3.1 Global Female Contraceptive Devices Market Revenue, by Device Type, 2012 – 2020 (USD Million)
4.3.3.2 Female Condoms
4.3.3.2.1 Global Female Condoms Market Revenue, 2012 – 2020 (USD Million)
4.3.3.3 Contraceptive Diaphragms
4.3.3.3.1 Global Contraceptive Diaphragms Market Revenue, 2012 – 2020 (USD Million)
4.3.3.4 Contraceptive Sponges
4.3.3.4.1 Global Contraceptive Sponges Market Revenue, 2012 – 2020 (USD Million)
4.3.3.5 Contraceptive Vaginal Rings
4.3.3.5.1 Global Contraceptive Vaginal Rings Market Revenue, 2012 – 2020 (USD Million)
4.3.3.6 Intrauterine Devices
4.3.3.6.1 Global Intrauterine Devices Market Revenue, 2012 – 2020 (USD Million)
4.3.3.7 Subdermal Contraceptive Implants
4.3.3.7.1 Global Subdermal Implants Market Revenue, 2012 – 2020 (USD Million)
4.3.3.8 Non-Surgical Permanent Contraception Devices
4.3.3.8.1 Global Non-Surgical Permanent Contraception Devices Market Revenue, 2012 – 2020 (USD Million)

Chapter 5 Global Contraceptives Market, by Geography
5.1 Overview
5.1.1 Global Contraceptives Market Revenue, by Geography, 2012 – 2020 (USD Million)
5.2 North America
5.2.1 North America Contraceptives Market Revenue, 2012 – 2020 (USD Million)
5.2.2 North America Contraceptives Market, by Products (Drugs & Devices), 2012 – 2020 (USD Million)
5.3 Europe
5.3.1 Europe Contraceptives Market Revenue, 2012 – 2020 (USD Million)
5.3.2 Europe Contraceptives Market, by Products (Drugs & Devices), 2012 – 2020 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific Contraceptives Market Revenue, 2012 – 2020 (USD Million)
5.4.2 Asia Pacific Contraceptives Market, by Products (Drugs & Devices), 2012 – 2020 (USD Million)
5.5 Rest of the World (RoW)
5.5.1 Rest of the World Contraceptives Market Revenue, 2012 – 2020 (USD Million)
5.5.2 Rest of the World Contraceptives Market, by Products (Drugs & Devices), 2012 – 2020 (USD Million)

Chapter 6 Recommendations
6.1 Investing in Emerging Economies such as India and China and Underdeveloped African Economies
6.2 Making Rigorous R&D Initiatives
6.3 Investing in Marketing Campaigns to Elevate Customer Awareness
6.4 Tracking Patent Expiration of Branded Products

Chapter 7 Company Profiles
7.1 Actavis, Inc.
7.1.1 Company Overview
7.1.2 Financial Overview
7.1.3 Product Portfolio
7.1.4 Business Strategies
7.1.5 Recent Developments
7.2 Bayer AG
7.2.1 Company Overview
7.2.2 Financial Overview
7.2.3 Product Portfolio
7.2.4 Business Strategies
7.2.5 Recent Developments
7.3 Church & Dwight Co., Inc.
7.3.1 Company Overview
7.3.2 Financial Overview
7.3.3 Product Portfolio
7.3.4 Business Strategies
7.3.5 Recent Developments
7.4 CooperSurgical, Inc.
7.4.1 Company Overview
7.4.2 Financial Overview
7.4.3 Product Portfolio
7.4.4 Business Strategies
7.4.5 Recent Developments
7.5 Mayer Laboratories, Inc.
7.5.1 Company Overview
7.5.2 Financial Overview
7.5.3 Product Portfolio
7.5.4 Business Strategies
7.5.5 Recent Developments
7.6 Merck & Co., Inc.
7.6.1 Company Overview
7.6.2 Financial Overview
7.6.3 Product Portfolio
7.6.4 Business Strategies
7.6.5 Recent Developments
7.7 Pfizer, Inc.
7.7.1 Company Overview
7.7.2 Financial Overview
7.7.3 Product Portfolio
7.7.4 Business Strategies
7.7.5 Recent Developments
7.8 Reckitt Benckiser plc
7.8.1 Company Overview
7.8.2 Financial Overview
7.8.3 Product Portfolio
7.8.4 Business Strategies
7.8.5 Recent Developments
7.9 Teva Pharmaceutical Industries Ltd.
7.9.1 Company Overview
7.9.2 Financial Overview
7.9.3 Product Portfolio
7.9.4 Business Strategies
7.9.5 Recent Developments
7.10 The Female Health Company
7.10.1 Company Overview
7.10.2 Financial Overview
7.10.3 Product Portfolio
7.10.4 Business Strategies
7.10.5 Recent Developments

List of Table


TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Contraceptives Market
TABLE 3 Side Effects Associated with the Use of Contraceptive Drugs and Devices
TABLE 4 Global Contraceptive Drugs Market Revenue, by Drug Type, 2012 – 2020 (USD Million)
TABLE 5 Global Female Contraceptive Devices Market Revenue, by Device Type, 2012 – 2020 (USD Million)
TABLE 6 Global Intrauterine Devices Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 7 Global Contraceptives Market Revenue, by Geography, 2012 – 2020 (USD Million)
TABLE 8 North America Contraceptives Market Revenue, by Types (Drugs and Devices), 2012 – 2020 (USD Million)
TABLE 9 Europe Contraceptives Market Revenue, by Types (Drugs and Devices), 2012 – 2020 (USD Million)
TABLE 10 Asia Pacific Contraceptives Market Revenue, by Products (Drugs and Devices), 2012 – 2020 (USD Million)
TABLE 11 Rest of the World Contraceptives Market Revenue, by Products (Drugs and Devices), 2012 – 2020 (USD Million)

List of Chart


FIG. 1 Contraceptives Market Segmentation
FIG. 2 Global Contraceptive Drugs Market, by Product, 2013 (USD Million)
FIG. 3 Global Contraceptive Devices Market, by Product, 2013 (USD Million)
FIG. 4 Comparative Analysis: Global Contraceptives Market, by Geography, 2013 & 2020 (Value %)
FIG. 5 Number of People Aged 60 or Over: Developed and Developing Countries, 1950 - 2050
FIG. 6 Average Percentage of Women with Unmet Contraceptive Needs in the Southeast Asian, South Central Asian and Sub-Saharan African countries, 2011 (%)
FIG. 7 Porter’s Five Forces Analysis: Global Contraceptives Market
FIG. 8 Market Attractiveness Analysis: Global Contraceptives Market, by Geography
FIG. 9 Heat Map Analysis for Key Market Players: Global Contraceptive Drugs Market
FIG. 10 Heat Map Analysis for Key Market Players: Global Contraceptive Devices Market
FIG. 11 Comparative Analysis of the Global Contraceptives Market Revenue, by Product Type, 2013 & 2020 (%)
FIG. 12 Global Oral Contraceptive Pills Market Revenue, 2012 – 2020 (USD Million)
FIG. 13 Global Contraceptive Injectables Market Revenue, 2012 – 2020 (USD Million)
FIG. 14 Global Topical Contraceptives Market Revenue, 2012 – 2020 (USD Million)
FIG. 15 Comparative Analysis of the Global Contraceptive Devices Market, by Device Type, 2013 & 2020 (%)
FIG. 16 Global Male Contraceptive Devices Market Revenue, 2012 – 2020 (USD Million)
FIG. 17 Global Female Condoms Market Revenue, 2012 – 2020 (USD Million)
FIG. 18 Global Contraceptive Diaphragms Market Revenue, 2012 – 2020 (USD Million)
FIG. 19 Global Contraceptive Sponges Market Revenue, 2012 – 2020 (USD Million)
FIG. 20 Global Contraceptive Vaginal Rings Market Revenue, 2012 – 2020 (USD Million)
FIG. 21 Global Intrauterine Devices Market Revenue, 2012 – 2020 (USD Million)
FIG. 22 Global Sub-dermal Implants Market Revenue, 2012 – 2020 (USD Million)
FIG. 23 Global Non-Surgical Permanent Contraceptive Devices Market Revenue, 2012 – 2020 (USD Million)
FIG. 24 North America Contraceptives Market Revenue, 2012 – 2020 (USD Million)
FIG. 25 Europe Contraceptives Market Revenue, 2012 – 2020 (USD Million)
FIG. 26 Asia Pacific Contraceptives Market Revenue, 2012 – 2020 (USD Million)
FIG. 27 Rest of the World Contraceptives Market Revenue, 2012 – 2020 (USD Million)
FIG. 28 Actavis, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 29 Bayer AG: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 30 Church & Dwight Co., Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 31 CooperSurgical, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 32 Merck & Co., Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 33 Pfizer, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 34 Reckitt Benckiser Group plc: Annual Revenue, 2011 - 2013 (USD Million)
FIG. 35 Teva Pharmaceutical Industries Ltd.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 36 The Female Health Company: Annual Revenue, 2011 – 2013 (USD Million)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *

Upcoming Reports